Current state of liposome-complexed drugs in the treatment of cancer patients
- 1 June 1992
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 3 (6) , 419-421
- https://doi.org/10.1093/oxfordjournals.annonc.a058226
Abstract
E. G. E. de Vries, N.H. Mulder, T. Daemen; Editorial: Current state of liposome-complexed drugs in the treatment of cancer patients, Annals of Oncology, VolumeKeywords
This publication has 18 references indexed in Scilit:
- Phase I Trial of ImmTher, a New Liposome-Incorporated Lipophilic Disaccharide TripeptideJournal of Immunotherapy, 1991
- Antitumor Activity of Liposome-Encapsulated Doxorubicin in Advanced Breast Cancer: Phase II StudyJNCI Journal of the National Cancer Institute, 1990
- Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomesThe Lancet, 1990
- Therapy of Murine Liver Metastases by Administration of MDP Encapsulated in LiposomesSelective Cancer Therapeutics, 1990
- Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyEuropean Journal of Cancer and Clinical Oncology, 1989
- Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl TripeptideJNCI Journal of the National Cancer Institute, 1989
- A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.Journal of Clinical Investigation, 1983
- Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.Proceedings of the National Academy of Sciences, 1981
- In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomesCellular Immunology, 1981